New products to drive systemic sclerosis market to $1.8 bn by 2030: GlobalData EP News Bureau Jun 18, 2021 GlobalData expects Ofev and Actemra/RoActemra to reach peak global sales of $508.8 million in 2025 and $163.2 million in 2024,…
Diagnosed prevalent cases of systemic sclerosis in 7MM to reach 187,000 by 2030: GlobalData EP News Bureau Jun 3, 2021 The US will have the highest number of diagnosed prevalent cases of systemic sclerosis in the 7MM at 114,000
DCGI approves Nintedanib for the treatment of systemic sclerosis-associated interstitial lung… EP News Bureau May 20, 2020 Approval is based on the SENSCIS study which showed Nintedanib slows the loss of pulmonary function in people living with systemic…
